Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 17;60(6):990.
doi: 10.3390/medicina60060990.

Deep Learning in Neovascular Age-Related Macular Degeneration

Affiliations
Review

Deep Learning in Neovascular Age-Related Macular Degeneration

Enrico Borrelli et al. Medicina (Kaunas). .

Abstract

Background and objectives: Age-related macular degeneration (AMD) is a complex and multifactorial condition that can lead to permanent vision loss once it progresses to the neovascular exudative stage. This review aims to summarize the use of deep learning in neovascular AMD. Materials and Methods: Pubmed search. Results: Deep learning has demonstrated effectiveness in analyzing structural OCT images in patients with neovascular AMD. This review outlines the role of deep learning in identifying and measuring biomarkers linked to an elevated risk of transitioning to the neovascular form of AMD. Additionally, deep learning techniques can quantify critical OCT features associated with neovascular AMD, which have prognostic implications for these patients. Incorporating deep learning into the assessment of neovascular AMD eyes holds promise for enhancing clinical management strategies for affected individuals. Conclusion: Several studies have demonstrated effectiveness of deep learning in assessing neovascular AMD patients and this has a promising role in the assessment of these patients.

Keywords: age-related macular degeneration; artificial intelligence; biomarker; deep learning; neovascular age-related macular degeneration; neovascularization; optical coherence tomography.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Article review and selection process.

References

    1. Daien V., Finger R.P., Talks J.S., Mitchell P., Wong T.Y., Sakamoto T., Eldem B.M., Korobelnik J.F. Evolution of treatment paradigms in neovascular age-related macular degeneration: A review of real-world evidence. Br. J. Ophthalmol. 2020;105:1475–1479. doi: 10.1136/bjophthalmol-2020-317434. - DOI - PMC - PubMed
    1. Souied E.H., Benlian P., Amouyel P., Feingold J., Lagarde J.P., Munnich A., Kaplan J., Coscas G., Soubrane G. The ε4 allele of the Apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am. J. Ophthalmol. 1998;125:353–359. doi: 10.1016/S0002-9394(99)80146-9. - DOI - PubMed
    1. Borrelli E., Reibaldi M., Barresi C., Berni A., Introini U., Bandello F. Choroidal Hyper-Reflective Foci in Geographic Atrophy. Investig. Ophthalmol. Vis. Sci. 2023;64:5. doi: 10.1167/iovs.64.14.5. - DOI - PMC - PubMed
    1. Borrelli E., Berni A., Mastropasqua L., Querques G., Sadda S.R., Sarraf D., Bandello F. Pushing Retinal Imaging Forward: Innovations and Their Clinical Meaning—The 2022 Ophthalmologica Lecture. Ophthalmologica. 2023;246:278–294. doi: 10.1159/000533910. - DOI - PubMed
    1. Barresi C., Chhablani J., Dolz-Marco R., Gallego-Pinazo R., Berni A., Bandello F., Borrelli E. Retinal neurodegeneration in age-related macular degeneration. Eur. J. Ophthalmol. 2023;34:624–630. doi: 10.1177/11206721231186166. - DOI - PubMed